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A 15-month-old boy was admitted because of sudden onset of 
multiple painless papulonodular lesions of 2 weeks' duration. Past 
medical history was unremarkable. Physical examination revealed 
12 erythematous, ulcerated papules and nodules, ranging from 1 to 
5 cm, some with a central necrotic crust located on the trunk, limbs, 
genital area, and the left upper eyelid (Figures 1 and 2). Persistent 
fever (39°C) was noted without other relevant findings. Laboratory 
evaluation revealed severe microcytic anemia (hemoglobin: 7.4 g/
dL; mean corpuscular volume: 53.3 fL) with elevated C-reactive pro-
tein (87.6 mg/dL) and erythrocyte sedimentation rate (45 mm/h). No 
atypia was observed within the circulating blood cells. Cultures for 
bacteria, mycobacteria, and fungi were negative. Excisional skin bi-
opsy of an abdominal nodule was performed (Figures 3 and 4).
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WHAT IS YOUR DIAGNOSIS?




The excisional biopsy specimen revealed a dense lymphoid dermal 
infiltrate composed of pleomorphic CD3+ CD4+ cells and large 
clusters of CD30+ cells (Figures 5 and 6), with atypical mitoses and 
necrotic foci. Histiocytes and rare neutrophils were also identified. 
The diagnosis of lymphomatoid papulosis (LyP), subtype A, was es-
tablished. No therapy was administered, and spontaneous remission 
was documented after 14 weeks, with only residual postinflamma-
tory hyperpigmentation.
Lymphomatoid papulosis is a self-regressing, chronic disorder. 
It is clinically characterized by the eruption of erythematous, papu-
lonecrotic, and nodular lesions, which may appear anywhere on the 
body surface. Histopathologically, LyP shows features resembling 
CD30-positive T-cell lymphoma.1-4 LyP is included in the spectrum 
of primary cutaneous CD30-positive T-cell lymphoproliferative 
disorders, according to the World Health Organization.3 It has a 
favorable prognosis, with a 10-year survival rate close to 100%. 
Nevertheless, the link with future onset of malignant lymphomas 
has been established, underscoring the need for regular long-term 
surveillance.5-7 LyP is rarely diagnosed in children, and its peak age 
of onset is around the fifth decade.1,6 According to a systematic re-
view published in 2016, only 251 pediatric patients were reported 
with LyP, worldwide,1 with a mean age at diagnosis of 9.3 ± 4.6 years. 
The clinical characteristics of LyP in children do not seem to differ 
substantially from those in adults.7 Papular presentation (reported 
in 59% of the cases) is the most common, followed by predominance 
of nodular lesions in 31.5% of the patients.1 Ulceration and necrosis 
were observed in 13.5% and 7.2%, respectively.1
Our patient is one of the youngest reported cases.1,2 His severe 
presentation, with sustained high fever and the emergence of multi-
ple ulcerated nodules, raised the differential diagnosis of infectious 
etiologies such as ecthyma or ecthyma gangrenosum, as well as 
pityriasis lichenoides et varioliformis acuta (PLEVA). About 36% of 
the patients included in a pediatric case series of LyP had a previ-
ous, concomitant, or retrospective diagnosis of pityriasis lichenoides 
(PL), with their lesions described as smaller and more numerous than 
those of LyP. Additionally, these lesions were not vesicular, pustular, 
or nodular.2 A rare, severe variant of PLEVA, febrile ulceronecrotic 
Mucha-Habermann disease (FUMHD), is characterized by a clinical 
picture similar to our patient's presentation, with sudden onset of 
ulceronecrotic skin lesions associated with high fever and systemic 
symptoms, commonly affecting children.8 However, compared to 
LyP, the cutaneous lesions of FUHMD tend to be more general-
ized and associated with mucosal involvement in 25% of the cases. 
Histopathology is distinctive showing a predominance of CD8+ T 
cells in the lymphocytic infiltrate; rarely, atypical lymphoid cells or 
CD30+ lymphoid cells, organized in a nonspecific pattern, may be 
seen in FUHMD skin biopsies.9 In the differential diagnosis of LyP, 
it is mandatory to exclude primary cutaneous CD30+ anaplastic 
large-cell lymphoma (PCALCL), which is an entity in the spectrum of 
the primary cutaneous CD30-positive lymphoproliferative disorders. 
Normally, PCALCL presents as a solitary nodule or tumor, although 
multiple lesions can be found. On immunohistochemistry, CD30 
must be expressed by the majority (>75%) of the neoplastic cells.4 
It is not a self-limited disease, but requires treatment, which can be 
surgical resection, localized radiotherapy, or, in cases of extracuta-
neous dissemination, systemic chemotherapy/ immunotherapy.4
Histopathology is necessary to achieve a definite diagnosis of 
LyP.3,5 The recognition of the 6 different LyP subtypes (A to F) is 
important to avoid misdiagnosis, but has no therapeutic or prognos-
tic implications.3 Similar to the adult paradigm, the most common 
histologic subtype reported in children is type A (79.1%),1 also the 
type identified in our clinical case. The self-remitting course of LyP, 
usually within 12 weeks,2 was also observed in our patient, with only 
supportive treatment performed. There has been no evidence of re-
lapse or recurrence in 6 months of follow-up.
While rare, it is important to consider LyP in the differential diag-
nosis of an ulcerated papulonodular eruption in infants. Because of 
the risk of subsequent systemic malignant lymphoma, the diagnosis 
of LyP in children raises important prognostic and management is-
sues, with the need for close long-term monitoring.
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